2 September, 2024Asahi Kasei completes the recommended public cash offer and becomes the owner of 93.30 per cent of all shares in Calliditas
25 July, 2024Inventiva secures a new patent in Japan, expanding the IP protection of its lead product candidate lanifibranor
23 July, 2024Sensorion announces positive recommendation from the Data Safety Monitoring Board (DSMB) regarding the continuation of NOTOXIS, its Phase 2a clinical trial of SENS-401 in cisplatin-induced ototoxicity